Autophagy Dysfunction in ALS: from Transport to Protein Degradation
- PMID: 35708843
- PMCID: PMC9293831
- DOI: 10.1007/s12031-022-02029-3
Autophagy Dysfunction in ALS: from Transport to Protein Degradation
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting upper and lower motor neurons (MNs). Since the identification of the first ALS mutation in 1993, more than 40 genes have been associated with the disorder. The most frequent genetic causes of ALS are represented by mutated genes whose products challenge proteostasis, becoming unable to properly fold and consequently aggregating into inclusions that impose proteotoxic stress on affected cells. In this context, increasing evidence supports the central role played by autophagy dysfunctions in the pathogenesis of ALS. Indeed, in early stages of disease, high levels of proteins involved in autophagy are present in ALS MNs; but at the same time, with neurodegeneration progression, autophagy-mediated degradation decreases, often as a result of the accumulation of toxic protein aggregates in affected cells. Autophagy is a complex multistep pathway that has a central role in maintaining cellular homeostasis. Several proteins are involved in its tight regulation, and importantly a relevant fraction of ALS-related genes encodes products that directly take part in autophagy, further underlining the relevance of this key protein degradation system in disease onset and progression. In this review, we report the most relevant findings concerning ALS genes whose products are involved in the several steps of the autophagic pathway, from phagophore formation to autophagosome maturation and transport and finally to substrate degradation.
Keywords: Amyotrophic lateral sclerosis; Animal models; Autophagy; Mutations.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.Autophagy. 2011 Apr;7(4):412-25. doi: 10.4161/auto.7.4.14541. Epub 2011 Apr 1. Autophagy. 2011. PMID: 21193837
-
Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.Mol Neurobiol. 2018 Aug;55(8):6480-6499. doi: 10.1007/s12035-017-0856-0. Epub 2018 Jan 10. Mol Neurobiol. 2018. PMID: 29322304 Review.
-
Autophagy dysregulation in amyotrophic lateral sclerosis.Brain Pathol. 2012 Jan;22(1):110-6. doi: 10.1111/j.1750-3639.2011.00546.x. Brain Pathol. 2012. PMID: 22150926 Free PMC article. Review.
-
Proteostasis impairment and ALS.Prog Biophys Mol Biol. 2022 Oct;174:3-27. doi: 10.1016/j.pbiomolbio.2022.06.001. Epub 2022 Jun 15. Prog Biophys Mol Biol. 2022. PMID: 35716729 Review.
-
MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.Autophagy. 2014 Apr;10(4):588-602. doi: 10.4161/auto.27710. Epub 2014 Jan 15. Autophagy. 2014. PMID: 24441414 Free PMC article.
Cited by
-
Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View.Cells. 2023 Sep 20;12(18):2318. doi: 10.3390/cells12182318. Cells. 2023. PMID: 37759540 Free PMC article. Review.
-
HLH-30/TFEB modulates autophagy to improve proteostasis in Aβ transgenic Caenorhabditis elegans.Front Pharmacol. 2024 Aug 30;15:1433030. doi: 10.3389/fphar.2024.1433030. eCollection 2024. Front Pharmacol. 2024. PMID: 39281281 Free PMC article.
-
Potential benefits of medium chain fatty acids in aging and neurodegenerative disease.Front Aging Neurosci. 2023 Aug 23;15:1230467. doi: 10.3389/fnagi.2023.1230467. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37680538 Free PMC article. Review.
-
Unraveling the Epigenetic Landscape: Insights into Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis.Brain Sci. 2024 May 29;14(6):553. doi: 10.3390/brainsci14060553. Brain Sci. 2024. PMID: 38928553 Free PMC article. Review.
-
Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches.Front Cell Neurosci. 2024 Jan 8;17:1307636. doi: 10.3389/fncel.2023.1307636. eCollection 2023. Front Cell Neurosci. 2024. PMID: 38259504 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous